A collection of disease information resources and questions answered by our Genetic and Rare Diseases Information Specialists for Acute promyelocytic. Trasplante de células madre. Tratamiento para la leucemia promielocítica aguda. Tratamiento para la leucemia monocítica aguda. Tratamiento para la AML en. acute promyelocytic leucemia presenting during pregnancy. Clin Leukemia ; Cardonick E, Iacobucci A. Use of chemotherapy during.
|Published (Last):||16 January 2014|
|PDF File Size:||20.95 Mb|
|ePub File Size:||1.20 Mb|
|Price:||Free* [*Free Regsitration Required]|
Aceptado el 6 de abril de The roles of both consolidation therapy with CT including anthracyclines as well as the maintenance therapy with ATRA, mercaptopurine and methotrexate have been also well defined.
In addition, we elected to deliver ATRA fully on an outpatient basis, thus diminishing hospitalization costs. All transretinoic acid ATRA. Annu Rev Med ; Treatment of acute promyelocytic leukemia: Ann Biol Clin ; This patient was immediately submitted to thromboembolectomy with the removal of a white thrombus. Medicin Univ ; 1: Blood ; 90 Suppl.
Report of the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia. Reverse transcription promieloxitica chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.
Brit J Haematol ; Suppl. Eur J Haematol ; Cytometry Communications in Clinical Cytometry ; The molecular remission was achieved after the administration of ATRA in five patients, whereas in the remaining eight, chemotherapy CT was required to finally achieve it. How to cite this article.
ATRA was given until reaching a complete hematological remission, as defined by usual criteria. Arterial thrombosis in acute promyelocytic leukemia.
Pathogenesis and management of acute promyelocytic leukemia. There were no instances of the ATRA syndrome. A single institution experience. Recibido el 4 de noviembre de Acute promyeloclocytic leukemia can present coagulopathies which are frequently very serious due to hemorrhagic conditions.
Treatment using anthracyclines and retinoids provide a good response.
¿Qué sucede si la leucemia mieloide aguda no responde o regresa después del tratamiento?
Kaplan EL, Meier P. Three patients received an autologous peripheral blood stem cell transplantation 4, 6, 9,19 after achieving the molecular remission, in two instances during the first CR and in one, during the second CR vide supra.
In this work a year-old male patient with acute arterial insufficiency was evaluated. Toxicity and survival in de novo patients. Blood ; 84 Suppl. All the contents of this journal, except where otherwise noted, is licensed under a Promielocltica Commons Attribution License.
¿Qué sucede si la leucemia mieloide aguda (AML) no responde o regresa después del tratamiento?
High frequency of acute promyelocytic leukemia in Mexican mestizos. Acute promyelocytic leukemia; arterial thrombosis; treatment; citogenetic remission. The development of arterial thrombosis is uncommon.
The method which we have previously published and employed to treat patients with PML, 13 includes prednisone during the first aguds weeks of treatment; this addition has resulted in the eradication of the ATRA syndrome, which in our hands is no longer a problem; prospective studies to define the definite role of steroids in this setting are needed.
Semin Hematol ; High frequency of acute promyelocytic leukemia promielocifica latinos with acute myeloid leukemia Letter.
Trombose arterial em leucemia promielocítica aguda
Am J Hematol ; Outpatient supportive therapy after induction to remission therapy in adult acute promielociticx leukaemia AML is feasible: Substantial progress has occurred in the treatment of APL because of improved understanding of the pathophysiology of the disease and identification of a molecular target.
Acute promyelocytic leukemia as a paradigm for targeted therapy. Cellular immunophenotypes in 97 adults with acute leukemia.